Rad18 functions at the cross-roads of three different DNA damage response (DDR) pathways involved in protecting stressed replication forks: homologous recombination repair, DNA inter-strand cross-link repair and DNA damage tolerance. Although Rad18 serves to facilitate replication of damaged genomes by promoting translesion synthesis (TLS), this comes at a cost of potentially error-prone lesion bypass. In contrast, loss of Rad18-dependent TLS potentiates the collapse of stalled forks and leads to incomplete genome replication. Given the pivotal nature with which Rad18 governs the fine balance between replication fidelity and genome stability, Rad18 levels and activity have a major impact on genomic integrity. Here, we identify the de-ubiquitylating enzyme USP7 as a critical regulator of Rad18 protein levels. Loss of USP7 destabilizes Rad18 and compromises UV-induced PCNA monoubiquitylation and Pol η recruitment to stalled replication forks. USP7-depleted cells also fail to elongate nascent daughter strand DNA following UV irradiation and show reduced DNA damage tolerance. We demonstrate that USP7 associates with Rad18 directly via a consensus USP7-binding motif and can disassemble Rad18-dependent poly-ubiquitin chains both in vitro and in vivo. Taken together, these observations identify USP7 as a novel component of the cellular DDR involved in preserving the genome stability.
INTRODUCTION
The ability to recognize and accurately repair damaged DNA is essential for viability. In addition to repair processes that actively remove DNA lesions, cells have evolved mechanisms for tolerating the presence of damaged DNA that interferes with DNA replication. DNA damage tolerance (DDT) mechanisms are important for maintaining ongoing replication of genomes containing unrepaired bulky DNA lesions that block conventional replicative DNA polymerases and disrupt replication fork progression.
It is becoming clear that post-translational modifications, especially ubiquitylation/de-ubiquitylation, have a major role in both DNA repair as well as the regulation of DDT during replication. 1 Bulky DNA lesions, for example, UV-induced cyclobutane pyrimidine dimers that block replicative DNA polymerases and thus stall replication forks, can activate the E3 ubiquitin ligase Rad18, which together with its E2-conjugating enzyme Rad6, catalyzes the mono-ubiquitylation of proliferating-cell nuclear antigen (PCNA) on lysine K164. [2] [3] [4] This modification of PCNA facilitates the binding of specialized translesion synthesis (TLS) DNA polymerases, which can efficiently synthesize past bulky DNA adducts. [5] [6] [7] [8] However, Rad18-mediated lesion bypass is inherently error-prone and must be used sparingly in order to avoid mutations. Rad18-deficient cells are TLS-compromised and hypo-mutagenic, [9] [10] [11] while ectopically over-expressed Rad18 results in DNA damage-independent PCNA monoubiquitylation and recruitment of TLS polymerases to replication forks. 12, 13 Therefore, appropriate control of Rad18 expression levels is important for balancing replication stress tolerance with mutagenesis.
In addition to regulating protein-protein interactions, ubiquitylation can also alter the stability, localization or functionality of a protein. In this respect, while mono-ubiquitylation of PCNA increases its interaction with TLS polymerases, the same modification on DNA polymerase eta renders the protein inactive by blocking both its nuclear localization signal and its ability to bind PCNA. 6 Similarly, the mono-ubiquitylation of Rad18 has also been proposed to negatively regulate the DDT pathway, through its ability to block its interaction with helicase-like transcription factor (HLTF) and SNF2 histone-linker PHD-finger RING-finger helicase; 14 two E3 ubiquitin ligases required to carry out error-free bypass of a DNA lesion. Moreover, in contrast to unmodified Rad18, which resides in the nucleus, the mono-ubiquitylated form of Rad18 has been shown to be predominantly localized to the cytoplasm, 15 suggesting that this modification may suppress Rad18 activity via multiple different mechanisms.
Removal of ubiquitin from mono-and poly-ubiquitylated proteins is also critical for determining the ubiquitylation state of various E3 ligase substrates. Increasingly, it is becoming clear that de-ubiquitylating (DUB) enzymes have major roles in controlling a wide variety of different cellular processes including the response to DNA damage. 16 One DUB that has received a lot of attention, primarily through its well-documented role in controlling the stability of the p53-directed E3 ubiquitin ligases MDM2 and MDMX, is the Herpes-associated ubiquitinspecific protease, USP7/Hausp. In unstressed cells, USP7 binds to and stabilizes MDM2/MDMX, which in turn promotes the poly-ubiquitylation of p53 and its subsequent destruction by the proteasome. 17 Upon induction of DNA damage, the interaction between USP7 and MDM2/MDMX is disrupted 18 by ataxiatelangiectasia mutated-dependent phosphorylation, 19 which functions to promote the ubiquitin-dependent destruction of MDM2/ MDMX, thus allowing p53 to accumulate. Originally identified through its association with the Herpes Simplex Virus E3 ligase ICP0, USP7 has been found to regulate the stability of a multitude of different cellular proteins many of which are E3 ubiquitin ligases, including CHFR and more recently, UHRF1 and HLTF. [20] [21] [22] [23] In addition to controlling protein stability, USP7 has also been reported to affect both the cellular compartmentalization and activity of a number of its substrates. 24 Here, we identify Rad18 as a novel USP7-binding partner and substrate. USP7-mediated de-ubiquitylation protects Rad18 from proteasomal degradation and is necessary for the integrity of the TLS pathway. Importantly, USP7-deficiency recapitulates key phenotypes of TLS-deficient cells including defective replication of damaged genomes and UV hypersensitivity. Owing to its key roles in multiple DNA damage signaling pathways, USP7 may allow coordination of Rad18-mediated TLS with other branches of the DDR including p53 signaling, Chk1 and Rad5-mediated postreplication repair. Moreover, since Rad18 confers tolerance to chemotherapeutic agents such as cisplatin and camptothecin, our results suggest a rationale for the use of USP7 inhibitors as chemosensitizers to treat tumors clinically.
RESULTS

USP7 depletion leads to destabilization of Rad18 protein levels
Given that Rad18 has been shown to undergo poly-ubiquitylation and proteasome-mediated degradation in vivo, 15 we hypothesized that this poly-ubiquitylation-coupled degradation maybe counteracted by a Rad18-targeted DUB activity. To test this hypothesis, we used siRNA to individually deplete a subset of DUBs, previously identified to function in the DNA damage response (DDR), 16 to determine what impact loss of these DUBs has on the stability of Rad18. Strikingly, we observed that compromising USP7 levels but not those of USP1, USP11, USP3 or USP28, resulted in a significant reduction in the levels of Rad18 (Figure 1a) . Importantly, the reduction in Rad18 levels was not due to siRNA 'off-target' effects as we obtained similar results using multiple different USP7-directed siRNAs (Figure 1b) . Moreover, USP7 − / − HCT116 cells expressed reduced levels of Rad18 when compared with the parental (USP7-expressing) HCT116 cells. In addition, pharmacological inhibition of USP7 using HBX19818 also recapitulated the effect of USP7-deficiency on Rad18 expression (Figure 1c) . Critically, this reduction of Rad18 protein levels in USP7-deficient cells could not be accounted for by any alterations in either Rad18 mRNA expression or cell cycle distribution (Supplementary Figures  1A and 1B) .
Treatment with the proteasome inhibitor MG132 partially rescued the reduced Rad18 protein levels resulting from either siRNA-mediated USP7 depletion (Figure 1d ), pharmacological inhibition of USP7 activity (Figure 1e, left panel) or inactivation of the USP7 gene (Figure 1e , right panel). Combined, these results indicate that Rad18 is actively degraded by the proteasome in response to loss of USP7 DUB activity. Crucially, re-expression of an siRNA-resistant wild type (WT) but not a catalytically inactive (dead) mutant USP7 in cells lacking endogenous USP7, substantially restored Rad18 levels demonstrating that the enzymatic activity of USP7 is necessary for maintaining normal Rad18 protein expression (Figure 1f ). Taken together, these data demonstrate that USP7 is important for maintaining cellular pools of Rad18 and that upon loss of this protection Rad18 is targeted for proteasomal degradation.
Cells lacking USP7 exhibit defects in the DNA damage tolerance pathway Given that loss of USP7 function led to a substantial reduction in Rad18 protein levels, we asked whether USP7-depletion would recapitulate hallmarks of Rad18-deficiency. First, we tested the effect of USP7-depletion on DNA damage-induced mono-ubiquitylation of PCNA, the best-characterized substrate of Rad18. Strikingly, USP7-deficient cells displayed a significant reduction in the levels of UV-induced PCNA mono-ubiquitylation (mUb-PCNA) when compared with cells expressing USP7 (Figure 2a and Supplementary Figure 2) .
One critical function of PCNA mono-ubiquitylation is to provide a docking site for TLS polymerases, 3, 5, 7, 8, 25, 26 for example DNA Pol η, which binds to mUb-PCNA through its PIP motif, ubiquitinbinding domain and PCNA interacting region. 3, 6, 7 As shown in Figure 2b , the UV-induced redistribution of Pol η to sites of replication fork stalling (determined by the quantification of cells with nuclear GFP-Pol η foci) was reduced by 40-60% in USP7-depleted cells relative to control siRNA transfected cells. Importantly, this was not due to an alteration in the levels of Pol η because they remained unaffected by USP7 depletion in multiple cell lines (Supplementary Figure 3) .
Due to an inability of replication forks to bypass bulky DNA lesions, DNA damage bypass deficient cells, such as those lacking Rad18, Polη or Rev1, exhibit defective elongation of nascent DNA strands following UV-treatment, termed a post-replication repair defect. 10, 27, 28 To ascertain whether USP7 knockdown would give rise to a deficiency in post-replication repair, we used alkaline sucrose gradient sedimentation centrifugation to determine the effects of USP7-depletion on the elongation rates of newlyreplicated DNA in UV-irradiated cells. Notably, the DNA sizedistribution profiles in Figure 2c show that USP7-depleted cells accumulated high molecular mass DNA at a reduced rate compared to control cells. More importantly, this effect was similar but not as severe to that observed in Rad18-deficient cells (Supplementary Figure 4) Therefore, USP7-deficiency leads to decreased chain elongation following UV-treatment, recapitulating a major phenotype of Rad18/TLS-deficient cells.
USP7 has also been shown to control the stability of HLTF (Supplementary Figure 5A and Qing et al. 23 ), which has recently been implicated in potentiating the levels of PCNA monoubiquitylation in response to replication stress. 29 Therefore, we considered the possibility that HLTF dysregulation may contribute to the TLS-related phenotype we observed in USP7-defective cells. However, despite HLTF expression being knockdown to almost undetectable levels, this had no impact on the levels of UVinduced PCNA mono-ubiquitylation, indicating that reduced HLTF levels in USP7-depleted cells do not account for the attenuation of PCNA mono-ubiquitylation (Supplementary Figure 5B) .
It has been shown that a deficiency in Rad18, Rev1 or DNA Polζ-dependent TLS gives rise to a hypo-mutagenic phenotype following UV irradiation [9] [10] [11] [30] [31] [32] [33] [34] [35] whereas HLTF depletion renders cells hyper-mutagenic, 29 Therefore, we determined the effect of USP7-depletion on mutagenesis using a plasmid-based reporter assay. 29 As shown in Figure 2d , USP7-depletion had no effect on spontaneous mutagenesis of an undamaged reporter plasmid. Strikingly, however, the mutation frequency of UV-damaged reporter plasmids was reduced by~50% in USP7-deficient cells when compared to control cells (Figure 2d ). This observation is in agreement with the hypo-mutagenic phenotype of Rad18/TLSdeficient cells following UV irradiation [9] [10] [11] [30] [31] [32] [33] [34] [35] and further indicates that reduced HLTF levels do not account for the postreplication repair defects we observed in cells lacking USP7. Furthermore, consistent with the phenotypes of Rad18/TLSdeficient cells, USP7-depletion conferred a modest hypersensitivity to agents that induce replication stress (including UV, MMC and HU) but not IR, which induces DSBs (Figure 2e ). To directly ascertain if a reduction in Rad18 expression is the underlying cause for the sub-optimal UV-induced monoubiquitylation of PCNA in USP7-depleted cells, we used an inducible cell system to allow for the controlled re-expression of Rad18 in USP7 siRNA transfected cells. HeLa cells expressing a doxycycline-inducible WT Flag-tagged Rad18 expression construct were transfected with USP7 siRNA and 72 h following transfection, doxycycline was added to the media for 24 h. The cells were then UV irradiated, harvested 6 h post irradiation and extracts analyzed by western blotting (Figure 2f ). As expected, in the absence of doxycycline, we found that cells depleted of USP7 exhibited a reduction in levels of PCNA mono-ubiquitylation (compare lanes 7 Figure 1 . Rad18 protein levels are reduced in USP7-deficient cells and can be restored by proteasomal inhibition. (a) HeLa cells were transfected with control siRNA or siRNA against USP7, USP1, USP28, USP3 or USP11. The cells were harvested and extracts from these cells were subjected to western blotting using the antibodies indicated. (b) HeLa cells were transfected with control siRNA, a single siRNA sequence targeting USP7 or a SMARTpool of USP7 siRNA sequences. The cells were harvested and extracts from these cells were subjected to western blotting using the antibodies indicated. The loading control is a non-specific band recognized by the anti-Rad18 antibody. (c) HeLa cells were incubated with increasing amounts of a specific USP7 inhibitor (HBX19818) for 24 h and the levels of USP7 and Rad18 monitored by western blotting (left panel). The loading control is a non-specific band recognized by the Rad18 antibody. The expression of Rad18 and USP7 was determined by western blotting on extracts derived from HCT116 cells either expressing USP7 (WT USP7) or in which USP7 had been knocked out (USP7 − / − ) (right panel). SMC1 was used as a loading control. (d) MRC5 cells were transfected with a single siRNA sequence targeting USP7 as in part 'b' and then incubated with MG132 for the indicated times. Extracts from these cells were subjected to SDS-polyacrylamide gel electrophoresis and western blotting with the antibodies indicated. (e) MRC5 cells were incubated with 15 μM of the USP7 inhibitor (HBX19818) for 16 or 24 h in the presence or absence of 10 μM MG132. The levels of USP7, Rad18 and H2A were monitored by western blotting (left panel). USP7
− / − cells were incubated in media containing either dimethylsulfoxide or MG132 and the levels of Rad18 determined by western blotting (right panel). Rad51 and Rad6 were used as loading controls. (f) HeLa cells were transfected with control or USP7 siRNA in conjunction with an empty vector, Flag-tagged WT USP7 or a catalytically dead USP7 mammalian expression construct. Extracts from these cells were subjected SDS-polyacrylamide gelelectrophoresis and western blotting with the antibodies indicated. USP7 controls Rad18 stability and DNA damage tolerance A Zlatanou et al with 3). However, this was restored upon re-expression of Rad18 following the addition of doxycycline (compare lanes 8 with 4). This observation is consistent with the premise that dysregulation of Rad18 levels accounts for the reduced PCNA monoubiquitylation in USP7-depleted cells. Taken together, our results demonstrate that USP7 confers Rad18 stability, and is necessary for Rad18 effector functions in response to the induction of genotoxic stress including Pol η redistribution to sites of UV lesions, replication of damaged genomes, mutagenesis and DDT.
USP7 associates with Rad18 and dismantles Rad18-dependent poly-ubiquitin chains in vitro and in vivo Since USP7 is implicated in regulating the stability of a number of different substrates, including several E3 ubiquitin ligases, we wished to examine whether the requirement for USP7 to maintain Rad18 levels was direct or mediated by a USP7-dependent pathway. To determine whether Rad18 and USP7 exist in a complex, we performed reciprocal immunoprecipitations to isolate ectopically co-expressed, epitope-tagged forms of Rad18 and WT or catalytically inactive (Dead) USP7 from HEK293 cell extracts. Notably, we observed a robust interaction between Rad18 and USP7 that was enhanced when the enzymatic activity of USP7 was ablated (Figure 3a) . Moreover, purified, recombinant forms of Rad18 and USP7 could also bind together in vitro (Figure 3b ) indicative that this interaction is direct.
Given that USP7 and Rad18 associate and that Rad18 autoubiquitylation has been proposed to target it for proteasomal degradation, 15 we reasoned that the dependence of Rad18 stability on USP7 could be a mediated through its ability to antagonize Rad18 auto-ubiquitylation. To address this, Rad18-dependent auto-ubiquitylation reactions were carried out in the presence or absence of recombinant purified WT and catalytically inactive USP7. Strikingly, the robust auto-ubiquitylation of Rad18, detected with either an anti-Rad18 or anti-poly-ubiquitin (FK2) antibody was completely abolished by the addition of WT but not DUB-dead USP7 (Figure 3c ), strongly indicating that USP7 is capable of antagonizing the E3 ubiquitin ligase activity of Rad18 in vitro. Moreover, the specificity of this USP7 activity was verified by the observation that the addition of recombinant USP25 (an irrelevant DUB) to the Rad18 auto-ubiquitylation reaction failed to reverse Rad18-dependent ubiquitin chain formation (Supplementary Figure 6) .
To ascertain whether Rad18 poly-ubiquitin chains are also targeted by USP7 in vivo, MRC5 cells were transfected with either WT ubiquitin or a mutant ubiquitin harboring a lysine-48 to arginine substitution (designated 'K48R', which cannot form poly-ubiquitin chains), together with either a WT or DUB Dead USP7 mammalian expression construct. The cells were then treated with MG132 to promote stabilization of poly-ubiquitin chains and a Rad18 antibody was used to detect endogenous poly-ubiquitylated Rad18. As shown in Figure 3d , endogenous Rad18 was modified by K48-linked poly-ubiquitin chains in vivo (compare lanes 3 with 5) that was suppressed by the overexpression of WT USP7 (compare lanes 3 with 6) but not by the catalytically inactive USP7 mutant (compare lanes 6 with 7). These results indicate that USP7 is a novel Rad18-directed DUB that removes K48-linked poly-ubiquitin chains generated via Rad18 auto-ubiquitylation.
Rad18 has a consensus USP7-binding motif required to maintain its stability in vivo To map the region of Rad18 responsible for mediating its binding to USP7, a panel of overlapping Rad18 fragments fused to GST was incubated with recombinant full-length USP7, co-associated proteins were purified on glutathione beads and detected by using western blotting (Figure 4a ). Interestingly, these binding studies identified amino acids 110-251 of Rad18 (which encompasses the ubiquitin-binding zinc motif) as the USP7-binding domain (Figure 4a) .
Notably, the region of Rad18 we identified as being necessary for its interaction with USP7 using in vitro binding assays (amino acids 110-251) contained two motifs conforming to the consensus USP7-binding sequence previously identified in other USP7 interacting proteins (P/AxxS: where position +1 is either a proline or alanine, x is any amino acid and position +4 is a serine, which has been shown to be critical for USP7-binding). 36 To ascertain if either of these binding motifs mediates the interaction with USP7, we mutated the consensus serine residues at amino acids 183 or 192/194 of Rad18 to alanine and then repeated the in vitro binding assays with the two mutant Rad18 fragments (Figure 4b ). Although mutation of the serine at position 183 on Rad18 had no effect on its interaction with USP7 in vitro, mutation of the two serines at position 192 and 194 in the second PxxS motif completely abolished USP7-binding (Figure 4b ). Co-immunoprecipitation analysis using extracts from 239T cells co-expressing full-length USP7 and either WT Rad18 or a S192/194A Rad18 mutant confirmed that the serine residues 192 and 194 in the Rad18 protein are also essential for binding to USP7 in vivo (Figure 4c ).
More importantly, in keeping with a role for this PxxS motif in modulating the stability of Rad18, analysis of in vivo protein half-life using cycloheximide in MRC5 cells revealed that the S192/194A mutant Rad18 is profoundly less stable than its WT counterpart (Figure 4d) . Furthermore, the accelerated degradation of this mutant Rad18 was completely abrogated in cells that were previously transfected with USP7 siRNA, indicating that the S192/194A mutation in Rad18 renders it more unstable than the WT protein only in the presence of USP7 (Figure 4e) . To ascertain the impact of this mutation on Rad18-dependent functions in response to UV irradiation, MRC5 cells were first transfected with Rad18 siRNA and 48 h later were further transfected with either an siRNA-resistant WT or S192/194A HA-tagged RAD18 expression construct or an empty vector. The cells were then UV irradiated Figure 3 . USP7 associates with and deubiquitylates Rad18 in vitro and in vivo. (a) 293FT cells were transfected with plasmids encoding EGFP-RAD18 and either WT or catalytically inactive (C223S) (DEAD) Flag-USP7. USP7 or Rad18 were immunoprecipitated from cell extracts using the indicated antibodies. The immunoprecipitated material was subjected to SDS-polyacrylamide gel electrophoresis/western blotting and the co-associated proteins detected with the indicated antibodies. (b) Purified Flag-tagged USP7 was incubated with purified Rad18 and immunoprecipitations were carried out using antibodies to either USP7 or Rad18. The immunoprecipitated material was subjected to SDSpolyacrylamide gel electrophoresis/western blotting and the co-associated proteins detected with the indicated antibodies. (c) Combinations of an E1 enzyme, an E2 enzyme (Rad6), Rad18 and ubiquitin were mixed and incubated for 3 h at 37°C. For de-ubiquitylation assays, after the 3 h ubiquitylation reaction, either recombinant WT or recombinant catalytically inactive (C223S) USP7 were added to the mix and the reactions were further incubated for 2 h at 37°C. In all cases the reactions were terminated by the addition of Laemli buffer and boiling for 10 min at 95°C. The proteins were detected by using the indicated antibodies. (d) MRC5 cells were transfected with plasmids encoding either WT or K48R ubiquitin (lanes 3-7) , in some cases with Flag-tagged RAD18 (lanes 2 and 4) and either WT or catalytically inactive Flag-tagged USP7 (lanes 6 and 7 respectively) and then incubated in MG132. Extracts from these cells were blotted for Rad18, Flag-USP7 and β-Tubulin. Normalized differences (fold change) in Rad18 poly-ubiquitylation intensity between samples were analyzed by densitometry and are depicted in red. and the levels of PCNA mono-ubiquitylation or GFP-Pol η re-localization were determined by western blotting (Figure 4f ) and immunofluorescence microscopy respectively (Figure 4f) . Interestingly, we noted that the S192/194A mutant HA-Rad18, when transiently expressed at similar levels to the WT protein, could efficiently promote both UV-induced mono-ubiquitylation of PCNA and also the relocalisation of GFP-Pol η to sites of damage. Therefore, we can conclude that the S192/194A Rad18 mutation does not adversely impact Rad18 function directly. However, a failure to bind USP7 renders the Rad18 S192/194A unstable and as a consequence, compromises its ability to effectively promote both PCNA mono-ubiquitylation and Pol η relocalisation to sites of UV stalled replication.
DISCUSSION
In our study, we identify a novel role for USP7 in regulating an important effector branch of the response to DNA damage, namely TLS. In particular, we demonstrate that the primary mechanism by which USP7 controls this pathway in response to replication damage is by regulating the stability of Rad18; the principal E3 ubiquitin ligase that directs activation of the DDT pathway through its ability to mono-ubiquitylate PCNA. Intracellular Rad18 levels can have a major influence on the activation state of the TLS pathway: reduced Rad18 expression attenuates PCNA mono-ubiquitylation and as a result compromises replication of damaged genomes. Consequently, this can lead to fork collapse, DSB formation and ultimately, cell death. 37 In addition, Rad18-deficiency also renders cells hypo-mutagenic owing to reduced activation of error-prone Y-family polymerases.
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Conversely, aberrant high-level expression of Rad18 can promote PCNA mono-ubiquitylation and drive recruitment of Y-family TLS polymerases to replication forks even in the absence of DNA damage. 12, 13 This could potentially increase mutation rates and potentiate cellular transformation. Therefore, it is clear that Rad18 expression levels can have a major influence on DDT, mutagenesis and the maintenance of genomic stability.
A recent report by Qian et al. 38 suggested that another component of the TLS pathway, Pol η, is a direct target of USP7-mediated de-ubiquitylation. 38 This study shows that the DUB activity of USP7 promotes the degradation of Pol η by stabilizing MDM2, which has been previously reported to poly-ubiquitylate Pol η. 39 Furthermore, the authors report that ectopic USP7 overexpression, can lead to increased Pol η stability, which they suggest promotes the mono-ubiquitylation of PCNA following UV irradiation in these cells. Our analysis demonstrates that USP7-depleted cells display reduced levels of Rad18 and as a result, defective PCNA mono-ubiquitylation and Pol η re-localization following UV irradiation. In contrast to the observation by Qian et al. 38 that USP7 loss increases Pol η stability, we have not detected any alterations either in Pol η protein levels or Pol η protein turnover in cells lacking USP7 (Supplementary Figures 3A-D) . However, even if Pol η stability is increased upon USP7 loss, based on our data, it would still not relocalise efficiently to sites of stalled replication in these cells (Figure 2b) . Moreover, the restoration of PCNA mono-ubiquitylation in USP7-deficient cells by the re-expression of Rad18 (Figure 2f ), further indicates that it is unlikely that the changes in PCNA mono-ubiquitylation levels are due to increased Pol η stability.
Although Rad18 function has been studied extensively, surprisingly little is known about how its expression levels are regulated. Our work underlines the importance of USP7 for Rad18 stability and as such for efficient DNA damage bypass. We have identified a consensus USP7-binding motif in Rad18 that protects the protein from accelerated degradation. Yamaizumi and colleagues demonstrated that Rad18 can poly-ubiquitylate itself and that this modified form of Rad18 can be targeted for degradation by the proteasome. 15 Our study identifies USP7 as a novel Rad18-directed DUB that removes poly-ubiquitin chains and antagonizes the proteasomal degradation of Rad18. However, whether the polyubiquitin-directed degradation of Rad18 is driven solely by its auto-ubiquitylation, remains unclear. Unfortunately, because of the inherent instability of catalytically inactive Rad18 RING domain mutants 40 we have been unable to ascertain whether Rad18 polyubiquitylation can occur independently of its catalytic activity. Moreover, we cannot rule out the involvement of other, as yet unidentified E3 ligases, contributing to the poly-ubiquitylation and subsequent degradation of Rad18.
In addition to poly-ubiquitylation, Rad18 is also monoubiquitylated in mammalian cells. Interestingly, in many of our experiments it appeared that the unmodified form of Rad18 is more susceptible to degradation in the absence of USP7 than the mono-ubiquitylated form. It is tempting to speculate that the mono-ubiquitylation of Rad18 makes it more resistant to poly-ubiquitylation and proteasomal dependent degradation. In support of this, it has been shown that the mono-ubiquitylated form of Rad18 is almost exclusively localized in the cytoplasm 15 whereas in contrast, USP7 is primarily localized in the nucleus. 41 As such, this could provide one explanation for the differential sensitivity of the unmodified versus mono-ubiquitylated forms of Rad18 to loss of USP7. Intriguingly, we also observed that even when USP7 is completely absent, the levels of Rad18 protein are never completely depleted. Although the underlying reason for this is unknown, this is consistent with a specific pool of Rad18, perhaps the mono-ubiquitylated form, being somehow protected from degradation and as such does not require the DUB activity of USP7. Moreover, since it is known that Rad18 exists as a dimer, it is possible that the unmodified Rad18 remaining in cells lacking USP7 is safeguarded from degradation through its association with a mono-ubiquitylated molecule of Rad18. In keeping with this, we repeatedly observed that the ratio of unmodified to mono-ubiquitylated forms in USP7-deficient cells shifted from a predomination of the unmodified form to stoichiometric amounts of both forms.
Recently, it has been suggested that the ubiquitylated form of Rad18 is inactive.
14 It was proposed that the mono-ubiquitylation of Rad18 is required to mediate its dimerization with another (unmodified) molecule of Rad18 resulting in its inactivation. However, following the induction of replication damage, the Rad18 dimer becomes de-ubiquitylated and subsequently activated. This observation highlights the point that regulating Rad18 ubiquitylation also plays a key role in controlling its activity. Currently, it is not clear whether USP7 contributes to the DNA damage-inducible removal of the mono-Ub from the inactive Rad18 homo-dimer, although at least in vitro, USP7 is capable of completely deubiquitylating Rad18. Interestingly, when we overexpressed USP7 to super-physiological levels in cells, rather than increasing the stability of Rad18, we observed a reduction in the mono-ubiquitylated form of Rad18. It is therefore possible that the elevated level of UV-induced PCNA mono-ubiquitylation in cells over-expressing USP7 reported by Qian et al. 38 is mediated through the de-ubiquitylation and activation of Rad18.
Since we have shown that USP7 is essential for maintaining Rad18 stability in cells and that loss of USP7 phenocopies the hallmark DDT defects associated with Rad18 deficiency, one inference from our work is that compromising USP7 function would be sufficiently detrimental to genomic integrity that it could potentiate cellular transformation. Interestingly, it has been recently demonstrated that a significant proportion of pediatric T-cell acute lymphoblastic leukemia tumor samples have acquired somatic, loss-of-function mutations in USP7. 42 Since ablating USP7 function results in p53 stabilization and an increase in p53-dependent G1 arrest and/or apoptosis, it is somewhat difficult to rationalize how these mutations would be beneficial for tumorigenesis unless they are acquired in tumor cells that already have an inactivated the p53 pathway. However, it is tempting to speculate that compromised Rad18-dependent DDT in USP7-defective tumor cells could permit the accumulation of DNA DSBs induced by replication stress, which if repaired inappropriately by non-homologous end-joining pathways, would give rise to the formation of gross genomic rearrangements; a process known to be necessary for transformation and/or disease progression.
Despite that USP7 has been shown to be important for regulating the stability of a number of different cellular proteins, its link to the p53 pathway has been the principal driver for the development of inhibitors to be used as anti-cancer treatments. However, since inhibiting USP7 primarily induces p53-dependent cell death, it is plausible that the frequent inactivation of TP53 would allow tumor cells to resist cell death following USP7 loss. In spite of this, our data suggests that USP7 inhibition could nevertheless sensitize tumors, (including those lacking functional p53), to genotoxic therapeutic agents such as cisplatin 43 or camptothecin 44 that are normally tolerated by cancer cells via Rad18-dependent mechanisms. As a consequence this work suggests that the potential therapeutic use of USP7 inhibitors could be widened to include those tumors with a defective p53 pathway, especially if combined with conventional chemotherapeutic agents. Figure 4 . A consensus USP7-binding motif in Rad18 is important for its stability. (a) Purified GST-tagged fragments of Rad18 were mixed with purified Flag-tagged USP7 and GST-pulldowns were performed as described in Materials and Methods. A schematic representation of the Rad18 fragments utilized is depicted (right panel). (b) GST-pulldowns were performed as in part 'a' but this time with a WT Rad18 fragment D or a mutant fragment D in which either S183 or S192/194 had been mutated to alanine (mutations denoted with X). The levels of co-precipitated USP7 were determined by western Blotting. USP7-binding motifs identified in proteins known to interact with USP7 are shown. A comparison with two putative USP7-binding motifs identified in Rad18 is also shown. (c) 293FT cells were treated as in Figure 3a , except that cells were transfected with full-length HA-tagged Rad18 (WT) or a mutant HA-tagged Rad18 where the serines S192 and 194 had been mutated to alanine and EGFP-USP7. HA-tagged Rad18 was immunoprecipitated from cell extracts using anti-HA antibodies and the immunoprecipitated material was subjected to SDS-polyacrylamide gel electrophoresis/western blotting and the co-associated proteins detected with the indicated antibodies. (d) MRC5 cells were transfected with an empty vector (v) or a construct expressing either WT HA-tagged Rad18 or the S192/194 A mutant HA-tagged Rad18. The cells were then incubated in media containing cycloheximide at a concentration of 60 μg/ml for the indicated periods. Extracts from these cells were fractionated by SDS-polyacrylamide gel electrophoresis and the levels of Rad18 determined by western blotting. β-Actin was used as a loading control. (e) MRC5 cells were treated as in part 'd' with the exception that prior to DNA transfection endogenous USP7 was knocked down with siRNA. Quantification by densitometry of normalized HA-Rad18 protein levels in each sample is depicted in the graphs below (d and e), respectively. (f) MRC5 cells were transfected with a single Rad18 siRNA sequence for 48 h and then with a siRNA-resistant WT or S192/194A HA-tagged Rad18 construct only (left panel). 24 h following transfection the cells were UV irradiated as indicated and 6 h later they were harvested. Extracts from the harvested cells were fractionated by SDS-polyacrylamide gel electrophoresis and HA-Rad18 expression and PCNA mono-ubiquitylation was monitored by western blotting. (left panel). These cells were additionally transfected with pEGPF-Pol η (right panel), fixed 6 h after UV irradiation and EGFP-Pol η localization was analyzed by fluorescence microscopy (right panel). At least 300 cells were analyzed per condition.
MATERIALS AND METHODS
Cell culture
HeLa, U2OS, 293T cells (ATCC) and 293FT (Invitrogen; Life Technologies, Paisley, UK) were maintained in DMEM (Gibco, Invitrogen; Life Technologies) supplemented with 10% fetal calf serum (FCS), glutamine and penicillin/streptomycin (pen/strep) at 37°C in 5% CO 2 . USP7 WT and knockout HCT116 cells were maintained in RPMI1640 (Gibco, Invitrogen) supplemented with 10% FCS, glutamine and penicillin/streptomycin (pen/ strep) at 37°C in 5% CO 2 . MRC5-SV40 cells were maintained in minimal essential media supplemented with 10% FCS and glutamine. Flp-In/T-rex HeLa cells were a kind gift from Dr Jakob Nilsson and maintained in DMEM supplemented with 10% FCS, glutamine, 200-μg/ml hygromycin and 5-μg/ml blasticidin. XP30RO (XP-Variant) or XP30R0 stably expressing POLH cDNA (XP30RO polη ) 45 were a kind gift from Dr Patricia Kannouche and were maintained in minimal essential media supplemented with 10% FCS and glutamine.
Chemicals/Inhibitors
Doxycycline (used at 200 ng/ml) was purchased from Sigma-Aldrich (Poole, UK). Cycloheximide used at used at 60 μg/ml was purchased from Merck Millipore (Darmstadt, Germany). The USP7 inhibitor HBX19818 was kindly provided by Dr Frédéric Colland (Hybrigenics) and has been previously reported elsewhere. 46, 47 
Plasmids
The GFP-and Flag-tagged USP7 expression constructs were obtained from Dr Madelon Maurice and have been previously described elsewhere. 19 The pEGFP-and Flag-Rad18 expression constructs were a kind gift from Drs Akira Yasui, Jun Huang and Junjie Chen and have been previously published. 48, 49 The plasmids encoding overlapping fragments of Rad18 fused to GST have been previously described. 50 Introduction of the S192/194A mutation in the RAD18 ORF was achieved using the sitedirected mutagenesis kit (Stratagene, Agilent Technologies, Wokingham, UK) according to the manufacturer's instructions using the following primers Forward: CGT CCT GAG CCA CCC GCG ACA GCC ACT TTG AAA CAA GTT ACT and Reverse: AGT AAC TTG TTT CAA AGT GGC TGT CGC GGG TGG CTC AGG ACG. For the introduction of the S183A mutation the primers used were: Forward: AA GAG ATC GCT CCA GAT CCC GCA GAG GCT AAG, Reverse: CTT AGC CTC TGC GCG ATC TGG AGC GAT CTC TT. Expression constructs for GFP-pol η and HA-tagged wt Rad18 were kindly provided by Dr Patricia Kannouche.
Antibodies and western blotting
The anti-USP7, SMC1, Rad18, Rad6, HLTF, USP1, USP11, USP3 and USP28 antibodies were all purchased from Bethyl (Universal Biologicals, Cambridge, UK). The histone H2A (acidic patch) antibodies were obtained from Millipore. Antibodies to PCNA, cyclin A, Cdt1 and Rad51 were obtained from Santa-Cruz (Dallas, TX, USA). The anti-Rad18, anti-Polη and β-Tubulin antibodies were all purchased from Abcam (Cambridge, UK) and the antipoly-ubiquitin (FK2) antibody was obtained from Biomol (Enzo Life Sciences, Exeter, UK). The anti-Flag (M2), β-actin and anti-HA epitope tag antibodies were purchased from Sigma-Aldrich. The anti-GFP (living colors) antibody was obtained from Clontech (Takara Bio Europe/SAS, SaintGermain-en-Laye, France).
siRNA and transfections
The siRNA duplexes were all 21 base pairs with a 2-base deoxynucleotide overhang. The sequence of the custom USP7 and control siRNA oligonucleotides used were: CCCAAATTATTCCGCGGCAAAdTdT and CGUACGCGGAAUACUUCGAdTdT, respectively (Fisher Scientific Ltd, Loughborough, UK). The Claspin, HLTF, USP1, USP3, USP11, USP28, DNA polymerase η (Polη) and USP7 (AAGCGUCCCUUUAGCAUUAUU, GCAUA GUGAUAAACCUGUAUU, UAAGGACCCUGCAAAUUAUUU, and GUAAAG AAGUAGACUAUCGUU) siRNA on-target plus SMARTpools and human RAD18 individual on-target plus oligonucleotide (GAAAUGAGU GGUUCUACAU) were all purchased from Fisher Scientific Ltd. Cells were transfected with siRNA duplexes using Oligofectamine (Invitrogen), following the manufacturer's instructions. Cells were routinely harvested 72 h post siRNA transfection. HeLa cells were transfected with a siRNAresistant Flag-USP7 expression construct using Lipofectamine 2000 (Life Technologies) according to the manufacturer's instructions.
Immunofluorescence
Following siRNA and pEGFP-Pol η transfections, HeLa or MRC5 cells were seeded onto coverslips and mock-irradiated or UV irradiated. Cells were washed twice in PBS, fixed in 3.6% paraformaldehyde at room temperature for 20 min and were then sealed with vectashield containing DAPI (Vectorlabs). All slides were analyzed by fluorescence microscopy at × 60 magnification (Nikon E600, Nikon UK Ltd, Kingston Upon Thames, Surrey, UK).
Colony survival
Cells transfected with siRNA were seeded at low density and exposed to a variety of DNA damaging agents. Cells were left for 14 days at 37°C to allow colonies to form. Colonies were stained with 2% methylene blue/ 50% ethanol and counted. Colonies were defined as containing 50 or more cells.
Post-replication repair assay
The assay was performed as previously described with minor modifications. 6 Mutagenesis assay 293T cells were transfected with non-target control or USP7-directed siRNAs using Lipofectamine 2000. After 24 h, the cells were transfected with an undamaged or UV-irradiated pSP189 reporter plasmid (Parris and Seidman 51 ) using Lipofectamine 2000. After 48 h, the pSP189 plasmid was recovered from the 293T cells using a DNA miniprep kit (QIAGEN, Hilden, Germany). Purified plasmid DNA was DpnI-digested and electroporated into the MBM7070 bacterial strain. The mutation frequency in the SupF coding region was determined by enumerating the ratios of blue (WT) and white (mutant) colonies.
Immunoprecipitation
293FT cells transfected with epitope-tagged USP7 and Rad18 expression constructs were lysed for 30 minutes in NETN lysis buffer (50-mM Tris/HCl pH 7.5, 150-mM NaCl, 1-mM EDTA, 2 mM MgCl 2 , 1% NP40 supplemented with protease inhibitors (Roche Diagnostics, Burgess Hill, UK) and Benzonase (Novagen, Merck Millipore). The clarified extract was precleared with the appropriate IgG (Dako, Agilent Technologies) and protein A or G beads (GE Healthcare, Little Chalfont, UK) for 1 h at 4°C. Immunoprecipitating antibody (10 μg) was added to the pre-cleared supernatant for 2.5 h followed by proteins A or G beads and incubated for 1.5 h at 4°C. The immuno-complexes were washed four times in NETN lysis buffer (containing 0.5% NP40), boiled in SDS sample buffer and loaded on an SDS-polyacrylamide gel. Proteins were analyzed by western blotting using standard methods and detected with the antibodies described above.
In vitro protein binding assay All reactions were conducted at 4°C unless otherwise stated. Immunoprecipitations using purified proteins were carried out as follows: 500 ng of purified USP7 (BostonBiochem, R&D Systems Europe Ltd, Abingdon, UK) and Rad18 (ORIGENE, Insight Biotechnology, Middlesex, UK) were mixed for 2 h at 4°C in a 500 μl reaction with NETN buffer (50-mM Tris pH 7.5, 1-mM EDTA, 150-mM NaCl and 0.5% NP-40) supplemented with a complete protease inhibitor cocktail (Roche Diagnostics). After this incubation, the reactions were span down at 44 000 r.p.m. for 15 min at 4°C and the supernatants were incubated with 0.5 μg of USP7 or Rad18 (Bethyl) or rabbit IgG (DAKO) polyclonal antibodies in separate reactions overnight. The following day, the reactions were span down at 13 000 r.p.m. for 5 min and the supernatants were mixed with 20 μl of protein A beads and left on a carousel for 2 h. The reactions were span down at 3 000 r.p.m. for 2 min and the supernatants discarded. The beads were washed three times in 1-ml NETN buffer (once in NETN with 150-mM NaCl followed by two washes in NETN with 400-mM NaCl) and were then re-suspended in 40-μl SDS sample buffer and boiled for 5 min at 95°C.
GST-pulldowns
All reactions were carried out at 4°C unless otherwise stated. Equal amounts of GST-Rad18 protein fragments were mixed each with 500 ng of purified His-tagged USP7 (Caltag Medsystems, Buckingham, UK) in 500 μl of NETN buffer (50-mM Tris pH 7.5, 1-mM EDTA, 150-mM NaCl and 1% NP-40) supplemented with complete protease inhibitor cocktail tablets (Roche Diagnostics) for 1 h and were then span down at 13 000 r.p.m. for a min. The supernatants were incubated for 1 h with 20 μl of GST-beads (per reaction) previously washed in the same buffer. After this incubation, the reactions were span down at 3000 r.p.m. for 2 min and the supernatants discarded. The beads were then washed five times in 1 ml NETN buffer and were then re-suspended in 40-μl SDS sample buffer and boiled for 5 min at 95°C.
In vitro ubiquitylation/de-ubiquitylation assays 0.2 μg of E1, 0.5 μg of E2 (Rad6), 0.5 μg of the E3 (Rad18) and 5 μg of ubiquitin were all mixed in a ubiquitylation reaction buffer containing 50 mM Tris pH7.5, 5 mM MgCl 2 , 1-mM DTT and 1xATP regeneration buffer (Enzo Life Sciences) in a final volume of 20μl for 3 h at 37°C. For de-ubiquitylation assays, after the 3 h ubiquitylation reaction, increasing amounts (0.5, 1, 1.5 μg) of purified USP7 (Caltag Medsystems) or 0.5 μg of recombinant WT or catalytically inactive (C223S) USP7 (A generous gift from Chris Boutell and Roger Everett) or WT USP25 (Enzo Life Sciences) were added to the mix (final volume of 30 μl) and the reactions were further incubated for 2 h at 37°C. In all cases reactions were terminated by the addition of SDS loading buffer and boiling for 10 min at 95°C.
Flow cytometry
PI analysis: Cells were stained with propidium iodide as previously described 52 and were analyzed by flow cytometry on an Accuri C6 flow cytometer (BD, Oxford, UK) using the manufacturer's software.
Quantitative RT-PCR (Q-PCR)
RNA was extracted using RNeasy kit (Qiagen) and complementary DNA was generated using Superscript II reverse transcriptase (Life Technologies). SYBR Green quantitative Real-time PCR (Life Technologies) was applied with primers against RAD18 (Fw: 5′-GCTTCTGGTGGATCAGGCTA-3′, Rev: 5′-TCAGGTTCCAATTCCTCTGG-3′). Primers against β-ACTIN (Fw: 5′-CACCATTGGCAATGAGCGGTTC, Rev: 5′-AGGTCTTTGCGGATGTCCACGT-3′) were used for normalization and quantification was achieved using the comparative Ct method. 53 
